As we age, the normally tightly regulated processes that guide our body's development and maintenance break down and can become dysfunctional. Though some of the mechanisms responsible for aging have been fairly well studied, a comprehensive model of how these various age-related pathologies manifest over time has yet to be clearly described. We hope that by tackling the various processes involved in aging, we can provide a comprehensive method of mitigating and even treating age-related diseases and frailty.
Metabolic disorders are a significant health burden in the United States. Metabolic syndrome is a cluster of conditions that include hypertension, hyperglycemia, and abnormal cholesterol and triglyceride levels. This results in a significantly increased risk of diabetes, heart attack, stroke and cancer. Metabolic disorders cause or contribute to more deaths in the developed world than all other causes. By understanding the underlying mechanisms behind this group of disorders, we seek to develop novel methods of preventing and treating these diseases.
Working with our academic and industry partners, we aim to develop the most advanced senolytic compounds that can effectively reduce senescent cells and maintain tissue function.
To maximize the bioavailability of a myriad of anti-aging compounds, we utilize a combination of advanced ingredient delivery technologies to achieve unparalleled absorption efficiency.